After Janssen Pharmaceuticals racked up more than $150,000 in vendor fees accessing medical records for plaintiffs filing suit in the Risperdal mass tort litigation, a dispute has flared up over how plaintiffs counsel should provide that information and whether they should be able to saddle defendants with the costs if plaintiffs counsel chooses to use a third-party vendor.

Over the past month, Janssen, a Johnson & Johnson subsidiary, has been sparring with the Houston-based law firm of Arnold & Itkin over who should have to pay $156,000 in costs after the Texas firm hired the vendor Lexitas to handle some of its clients’ records. The dispute is being litigated in the Philadelphia Court of Common Pleas, where nearly 7,000 cases are pending over Risperdal.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]